Nuclear effects of ethanol-induced proteasome inhibition in liver cells

World Journal of Gastroenterology

Volumn 15, Issue 10, 2009, Pages 1163-1167

  Bardag Gorce, Fawzia ^a  

^a UCLA MEDICAL CENTER   (United States)

Author keywords

Alcohol liver injury; Epigenetic mechanisms; Proteasome inhibition

Indexed keywords

ALCOHOL; HISTONE METHYLTRANSFERASE; NORETHISTERONE ACETATE; PROTEASOME; HISTONE;

ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ALCOHOL METABOLISM; CHROMATIN STRUCTURE; DNA METHYLATION; DNA MODIFICATION; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC EPIGENESIS; HYPERHOMOCYSTEINEMIA; IMMUNE RESPONSE; LIVER CELL; LONG TERM EXPOSURE; NONHUMAN; OXIDATIVE STRESS; REVIEW; UPREGULATION; APOPTOSIS; ARTICLE; CELL NUCLEUS; CHEMICALLY INDUCED DISORDER; DNA DAMAGE; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSCRIPTION; HUMAN; INFLAMMATION; LIVER; LIVER DISEASE; METABOLISM; PATHOLOGY;

APOPTOSIS; CELL NUCLEUS; DNA DAMAGE; ETHANOL; HISTONES; HUMANS; INFLAMMATION; LIVER; LIVER DISEASES; PROTEASOME ENDOPEPTIDASE COMPLEX; TRANSCRIPTION, GENETIC;

EID: 65649102188     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.1163     Document Type: Review

References (54)

1. Pajonk F, McBride WH. The proteasome in cancer biology and treatment. Radiat Res 2001; 156: 447-459
2. Rivett AJ, Hearn AR. Proteasome function in antigen presentation: immunoproteasome complexes. Peptide production, and interactions with viral proteins. Curr Protein Pept Sci 2004; 5: 153-161
3. Kleijnen MF, Roelofs J, Park S, Hathaway NA, Glickman M, King RW, Finley D. Stability of the proteasome can be regulated allosterically through engagement of its proteolytic active sites. Nat Struct Mol Biol 2007; 14: 1180-1188
4. Rechsteiner M, Hill CP. Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors. Trends Cell Biol 2005; 15: 27-33
5. Murata S, Udono H, Tanahashi N, Hamada N, Watanabe K, Adachi K, Yamano T, Yui K, Kobayashi N, Kasahara M, Tanaka K, Chiba T. Immunoproteasome assembly and antigen presentation in mice lacking both PA28alpha and PA28beta. EMBO J 2001; 20: 5898-5907
6. Ustrell V, Hoffman L, Pratt G, Rechsteiner M. PA200, a nuclear proteasome activator involved in DNA repair. EMBO J 2002; 21: 3516-3525
7. Cascio P, Goldberg AL. Preparation of hybrid (19S-20SPA28) proteasome complexes and analysis of peptides generated during protein degradation. Methods Enzymol 2005; 398: 336-352
8. Goldberg AL. Protein degradation and protection against misfolded or damaged proteins. Nature 2003; 426: 895-899
9. Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 2002; 82: 373-428
10. Pickart CM. Back to the future with ubiquitin. Cell 2004; 116: 181-190
11. Bardag-Gorce F, French BA, Nan L, Song H, Nguyen SK, Yong H, Dede J, French SW. CYP2E1 induced by ethanol causes oxidative stress, proteasome inhibition and cytokeratin aggresome (Mallory body-like) formation. Exp Mol Pathol 2006; 81: 191-201
12. Riley NE, Li J, Worrall S, Rothnagel JA, Swagell C, van Leeuwen FW, French SW. The Mallory body as an aggresome: in vitro studies. Exp Mol Pathol 2002; 72: 17-23
13. Osna NA, Donohue TM Jr. Implication of altered proteasome function in alcoholic liver injury. World J Gastroenterol 2007; 13: 4931-4937
14. Joshi-Barve S, Barve SS, Butt W, Klein J, McClain CJ. Inhibition of proteasome function leads to NF-kappaB-independent IL-8 expression in human hepatocytes. Hepatology 2003; 38: 1178-1187
15. Baker SP, Grant PA. The proteasome: not just degrading anymore. Cell 2005; 123: 361-363
16. Collins GA, Tansey WP. The proteasome: a utility tool for transcription? Curr Opin Genet Dev 2006; 16: 197-202
17. Kinyamu HK, Collins JB, Grissom SF, Hebbar PB, Archer TK. Genome wide transcriptional profiling in breast cancer cells reveals distinct changes in hormone receptor target genes and chromatin modifying enzymes after proteasome inhibition. Mol Carcinog 2008; 47: 845-885
18. Javerzat JP, McGurk G, Cranston G, Barreau C, Bernard P, Gordon C, Allshire R. Defects in components of the proteasome enhance transcriptional silencing at fission yeast centromeres and impair chromosome segregation. Mol Cell Biol 1999; 19: 5155-5165
19. Nalley K, Johnston SA, Kodadek T. Proteolytic turnover of the Gal4 transcription factor is not required for function in vivo. Nature 2006; 442: 1054-1057
20. von Mikecz A, Chen M, Rockel T, Scharf A. The nuclear ubiquitin-proteasome system: visualization of proteasomes, protein aggregates, and proteolysis in the cell nucleus. Methods Mol Biol 2008; 463: 191-202
21. O'Connell BC, Harper JW. Ubiquitin proteasome system (UPS): what can chromatin do for you? Curr Opin Cell Biol 2007; 19: 206-214
22. Hattori T, Kitagawa K, Uchida C, Oda T, Kitagawa M. Cks1 is degraded via the ubiquitin-proteasome pathway in a cell cycle-dependent manner. Genes Cells 2003; 8: 889-896
23. Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM, Pagano M. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med 1997; 3: 231-234
24. Kinyamu HK, Chen J, Archer TK. Linking the ubiquitinproteasome pathway to chromatin remodeling/modification by nuclear receptors. J Mol Endocrinol 2005; 34: 281-297
25. Bardag-Gorce F, French BA, Dedes J, Li J, French SW. Gene expression patterns of the liver in response to alcohol: in vivo and in vitro models compared. Exp Mol Pathol 2006; 80: 241-251
26. Cervantes-Laurean D, Roberts MJ, Jacobson EL, Jacobson MK. Nuclear proteasome activation and degradation of carboxymethylated histones in human keratinocytes following glyoxal treatment. Free Radic Biol Med 2005; 38: 786-795
27. Grune T, Reinheckel T, Joshi M, Davies KJ. Proteolysis in cultured liver epithelial cells during oxidative stress. Role of the multicatalytic proteinase complex, proteasome. J Biol Chem 1995; 270: 2344-2351
28. Bardag-Gorce F, Francis T, Nan L, Li J, He Lue Y, French BA, French SW. Modifications in P62 occur due to proteasome inhibition in alcoholic liver disease. Life Sci 2005; 77: 2594-602
29. Bardag-Gorce F, Li J, French BA, French SW. The effect of ethanol-induced CYP2E1 on proteasome activity: the role of 4-hydroxynonenal. Exp Mol Pathol 2005; 78: 109-115
30. Shukla SD, Velazquez J, French SW, Lu SC, Ticku MK, Zakhari S. Emerging role of epigenetics in the actions of alcohol. Alcohol Clin Exp Res 2008; 32: 1525-1534
31. Bardag-Gorce F, Oliva J, Villegas J, Fraley S, Amidi F, Li J, Dedes J, French B, French SW. Epigenetic mechanisms regulate Mallory Denk body formation in the livers of drug-primed mice. Exp Mol Pathol 2008; 84: 113-121
32. Li J, Bardag-Gorce F, Dedes J, French BA, Amidi F, Oliva J, French SW. S-adenosylmethionine prevents Mallory Denk body formation in drug-primed mice by inhibiting the epigenetic memory. Hepatology 2008; 47: 613-624
33. Martin GM. The genetics and epigenetics of altered proliferative homeostasis in ageing and cancer. Mech Ageing Dev 2007; 128: 9-12
34. Platta CS, Greenblatt DY, Kunnimalaiyaan M, Chen H. The HDAC inhibitor trichostatin A inhibits growth of small cell lung cancer cells. J Surg Res 2007; 142: 219-226
35. Oki Y, Issa JP. Review: recent clinical trials in epigenetic therapy. Rev Recent Clin Trials 2006; 1: 169-182
36. Mitsiades CS, Hayden PJ, Anderson KC, Richardson PG. From the bench to the bedside: emerging new treatments in multiple myeloma. Best Pract Res Clin Haematol 2007; 20: 797-816
37. Wiedmann MW, Caca K. Molecularly targeted therapy for gastrointestinal cancer. Curr Cancer Drug Targets 2005; 5: 171-193
38. Turner BM. Defining an epigenetic code. Nat Cell Biol 2007; 9: 2-6
39. Nightingale KP, O'Neill LP, Turner BM. Histone modifications: signalling receptors and potential elements of a heritable epigenetic code. Curr Opin Genet Dev 2006; 16: 125-136
40. Holliday R. Epigenetics: a historical overview. Epigenetics 2006; 1: 76-80
41. Ringrose L, Paro R. Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins. Annu Rev Genet 2004; 38: 413-443
42. Bardag-Gorce F, French BA, Joyce M, Baires M, Montgomery RO, Li J, French S. Histone acetyltransferase p300 modulates gene expression in an epigenetic manner at high blood alcohol levels. Exp Mol Pathol 2007; 82: 197-202
43. Kim JS, Shukla SD. Histone h3 modifications in rat hepatic stellate cells by ethanol. Alcohol Alcohol 2005; 40: 367-372
44. Fuks F, Hurd PJ, Deplus R, Kouzarides T. The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase. Nucleic Acids Res 2003; 31: 2305-2312
45. Tamaru H, Selker EU. A histone H3 methyltransferase controls DNA methylation in Neurospora crassa. Nature 2001; 414: 277-283
46. Jackson JP, Lindroth AM, Cao X, Jacobsen SE. Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase. Nature 2002; 416: 556-560
47. Fuks F, Hurd PJ, Wolf D, Nan X, Bird AP, Kouzarides T. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J Biol Chem 2003; 278: 4035-4040
48. Bardag-Gorce F, Oliva J, Dedes J, Li J, French BA, French SW. Chronic Ethanol Feeding Alters Hepatocyte Memory Which is not Altered by Acute Feeding. Alcohol Clin Exp Res 2009; [Epub ahead of print]
49. French SW. The pathogenesis and significance of the urinary alcohol cycle in rats fed ethanol intragastrically. Alcohol Clin Exp Res 2005; 29: 158S-161S
50. Oliva J, Dedes J, Li J, French SW, Bardag-Gorce F. Epigenetics of proteasome inhibition in the liver of rats fed ethanol chronically. World J Gastroenterol 2009; 15: 705-712
51. Ling YH, Liebes L, Jiang JD, Holland JF, Elliott PJ, Adams J, Muggia FM, Perez-Soler R. Mechanisms of proteasome inhibitor PS-341- induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines. Clin Cancer Res 2003; 9: 1145-1154
52. Dedes J, Li J, Bardag-Gorce F. Chromatin remodeling is regulated by the ubiquitin proteasome pathway. FASEB J 2008; 22: lb194
53. Dedes J, Li J, Bardag-Gorce F. Proteasome prevents DNA damage by regulating epigenetic modifications. RSA/ISBRA Scientific Meeting. Alcoholism: Clinical and experimental research. ACER 2008; 32: 99A
54. Lu SC, Mato JM. Role of methionine adenosyltransferase and S-adenosylmethionine in alcohol-associated liver cancer. Alcohol 2005; 35: 227-234